Overview
Status
Active
Registry date
2025-05-19
Share capital
45,000.00 PLN
Registered address
ul. Żmigrodzka 242E, 51-131 Wrocław, Poland
Electronic delivery address
AE:PL-51245-47227-BHDIT-27
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202501/04/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 0.21MedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -4.84kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 4.77kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 7.39kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Marek Noganowicz – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Jerzy Hanage 73 | 900 | $12,155.59 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-07-01.
09 1090 2398 0000 0001 6250 0707
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 29, 2025 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-01 | Name change (Iaso-Lek → Iaso-Lek Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2025-12-01 | Liquidation opened | |
| 2025-11-13 | Share capital increase (5,000.00 PLN → 45,000.00 PLN) | |
| 2025-05-19 | Entered in the register |
FAQ
The main business activity of Iaso-Lek focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on May 19, 2025.
The headquarters is located at: ul. Żmigrodzka 242E, 51-131 Wrocław.
The share capital of the company is PLN 45,000 (approx. $12,156).
Last updated: 2026-10-07